Publication | Closed Access
A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants
606
Citations
21
References
2000
Year
NutritionNeuropsychologyBrain DevelopmentMotor DevelopmentBrain NutritionExperimental NutritionInfant Formula MilkFatty AcidsCognitive DevelopmentDietary Docosahexaenoic AcidPublic HealthEarly Life ExposureHealth SciencesOmega-3 Fatty AcidEarly Childhood DevelopmentClinical NutritionRetina FoundationInfant CognitionChild DevelopmentEarly Dietary SupplyInfant NutritionPediatricsChild NutritionNutritional ScienceHuman NutritionMental Development
A randomized clinical trial fed term infants formula containing 0.35 % DHA, 0.36 % DHA + 0.72 % AA, or no DHA/AA, and assessed 56 18‑month‑old children with the Bayley Scales of Infant Development after earlier blood, VEP, and FPL measures. Infants receiving DHA + AA scored 7 points higher on the Bayley Mental Development Index, with significant gains in cognitive and motor subscales but not in language, psychomotor, or behavior, and early plasma/RBC DHA levels correlated with 18‑month MDI. Reference: Birch et al., 1998.
The effects of dietary docosahexaenoic acid (DHA) supply during infancy on later cognitive development of healthy term infants were evaluated in a randomized clinical trial of infant formula milk supplemented with 0.35% DHA or with 0.36% DHA and 0.72% arachidonic acid (AA), or control formula which provided no DHA or AA. Fifty-six 18-month-old children (26 male, 30 female) who were enrolled in the trial within the first 5 days of life and fed the assigned diet to 17 weeks of age were tested using the Bayley Scales of Infant Development, 2nd edition (BSID-II) (Bayley 1993) at the Retina Foundation of the Southwest, Dallas, TX. These children had also been assessed at 4 months and 12 months of age for blood fatty-acid composition, sweep visual evoked potential (VEP) acuity, and forced-choice preferential looking (FPL) acuity (Birch et al. 1998). Supplementation of infant formula with DHA+AA was associated with a mean increase of 7 points on the Mental Development Index (MDI) of the BSID-II. Both the cognitive and motor subscales of the MDI showed a significant developmental age advantage for DHA- and DHA+AA-supplemented groups over the control group. While a similar trend was found for the language subscale, it did not reach statistical significance. Neither the Psychomotor Development Index nor the Behavior Rating Scale of the BSID-II showed significant differences among diet groups, consistent with a specific advantage of DHA supplementation on mental development. Significant correlations between plasma and RBC-DHA at 4 months of age but not at 12 months of age and MDI at 18 months of age suggest that early dietary supply of DHA was a major dietary determinant of improved performance on the MDI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1